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Two methods which are simple, rapid and cost-effective are presented for 
determination of NTG in bulk and tablets using uv-spectrophotometry. Methods 
are based on measurement of absorbance of drug solution either in 0.1M NaOH 
at 210 nm (NaOH method) or in 0.1 M HCl at 270nm (HCl method). Beer’s law 
is obeyed over concentration ranges of 3-54 and 4-72 µg/mL for NaOH method 
and HCl method, respectively; and corresponding molar absorptivity values 
are 4.09 ×103 and 3.04 ×103 L/mol/cm. Calculated Sandell sensitivities are 
0.0776 and 0.0995 µgcm-2 with NaOH and HCl as diluents, respectively. Limits 
of detection (LOD) and quantification (LOQ), calculated according to the ICH 
guidelines are: 0.91 and 2.73µg/mL (NaOH method) and 0.72 and 2.16 µg/mL 
(HCl method). Intra-day and inter-day accuracy and precision, determined by 
replicate analyses at three concentration levels, were ≤2% (%RE) and ≤1.63% 
(%RSD), respectively. Method robustness was assessed by making small 
changes in the measurement wavelength whereas the ruggedness was tested 
by inter-analysts and inter-cuvettes variations. Validated methods were applied 
to the determination of active ingredient in tablets. Drug was subjected to forced 
degradation via acid and alkali hydrolysis, oxidation, thermolysis and photolysis.
Keywords: Nateglinide; Determination; UV Spectrophotometry; 
Pharmaceuticals; Stability-Indicating
Introduction
Nateglinide (NTG) is chemically known as [N-(trans-4- 
isopropylcyclohexyl carbonyl)-D-phenylalanine] (Figure 1) [1]. 
It is a D-phenylalanine derivative lacking either a sulphonylurea 
orbenzamido moiety and is a novel oral meal-time glucose regulator 
and has been approved for the treatment of diabetes mellitus [2,3]. 
This meglitinide derivative works by stimulating the pancreas to 
release insulin by closing the ATP-dependent potassium channels. 
The resulting influx of calcium induces insulin secretion. It is rapidly 
and completely absorbed from the gastrointestinal tract and peak 
plasma concentration reaches at 0.5-1.0 h. It is metabolized by 
cytochrome P-450 system to inactive metabolite and eliminated with 
half-life of 1.4h [4].
Due to its therapeutic importance, many methods based on 
diverse techniques, such as high-performance liquid chromatography 
[5-15], liquid-chromatography-tandem mass spectrometry [16-19] 
and micellarel ectrokinetic chromatography [20] have been reported 
for the determination of drug in body fluids. NTG is official in 
British Pharmacopoeia [21], Indian Pharmacopoeia [22], the United 
States Pharmacopoeia [23] and European Pharmacopoeia [24]. 
These pharmacopoeias describe liquid chromatographic method for 
assay of pure drug, but no method for dosage form. In addition to 
the pharmacopoeial methods, a number of spectrophotometric and 
chromatographic methods have been reported for the determination 
of NTG in pharmaceuticals, and include, visible spectrophotometry 
[25-30], high-performance thin layer chromatography [31,32] and 
HPLC [33-42].
Considering several advantageous aspects like simplicity, 
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speed, ease of performance, sensitivity and cost-effectiveness, uv-
spectrophotometry is perhaps the most widely used technique 
in the field of pharmaceutical analysis [43-48], and quite a few 
workers have applied this technique to the determination of NTG in 
pharmaceuticals. Rajasekaran et al [25] have reported a method in 
which the absorbance of pure drug and tablet extract in 95% ethanol 
was measured at 210nm. By measuring the absorbance in methanol, 
NTG in bulk form and tablets was assayed by Rastogi et al [49]. Jain 
et al [50] have developed two methods in which the absorbance of 
the drug solution or the tablet extract in methanol was measured at 
216nm or in a mixture of methanol and 10% NaOH (3N) at 225.4nm. 
Recording the absorbance of the bulk drug and tablet extract in 
phosphate buffer of pH 6.8, Babu et al [51] have devised three 
procedures in which the measurements were made at 217, 239 and 
248 nm. A stability-indicating method has been reported by Rahul 
and Vinod [52], where a mixture of 0.1N HCl and 0.5% sodium 
laurylsulphate was used as the medium and absorbance measured at 
212nm. Thomas and Patil [53] have reported two methods for the 
simultaneous determination of NTG and metformin hydrochloride 
Figure 1: Structure of NTG.
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(MFH) in tablets. First method involved solving simultaneous 
equations based on measurement of absorbance at 216nm (NTG) 
and 233nm (MFH). The second was the first derivative method, and 
the wavelengths selected for quantitation were 216nm for NTG and 
243nm for MFH. Beer’s law was obeyed over 0.5-80μg/mL for NTG 
and 0.5-40μg/mL for MFH in both methods.
Though several solvent systems have been employed for the uv-
spectrophotometric assay of NTG in pharmaceuticals, NaOH or 
HCl alone has not been used, and many reported methods [25,49-
53] have not been validated as per the ICH guidelines. Hence, 
the aim of the present study was to develop rapid and reliable uv-
spectrophotometric methods using 0.1N NaOH and 0.1 N HCl as 
diluents for the determination of NTG in bulk and tablet forms, 
and to validate them for linearity, LOD, LOQ, accuracy, precision, 
robustness, ruggedness and selectivity, following the ICH guidelines. 




Shimadzu Pharmaspec 1700UV/Visible double beam 
spectrophotometer provided with matched 1-cm quartz cells 
(Hyderabad, India) was used for all absorbance measurements.
All chemicals and reagents used were of analytical reagent 
grade and double distilled water was used throughout the study. 
Aqueous solution of hydrochloric acid (HCl, 5M) or sodium 
Figure 2: Absorption spectra of: a) 0.1M NaOH blank; b) NTG in 0.1M NaOH (36 μg mL-1 NTG); c) 0.1M HCl blank; d) NTG in 0.1M HCl (48 μg mL-1 NTG).
 
Figure 3: Calibration curve for NTG in: a) 0.1M NaOH, b) 0.1M HCl.
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hydroxide (NaOH, 5M) was prepared either by appropriate dilution 
of concentrated acid (S.D. Fine Chem Ltd, Mumbai, India) or by 
dissolving required quantity of chemical (Merck, Mumbai, India). 
Acid and alkali solutions, so prepared, were diluted stepwise to get 
0.1M concentrations and standardised. Hydrogen peroxide (5% v/v) 
was prepared by suitable dilution of commercial sample (30%, S.D. 
fine Chem, Mumbai, India).
Pure sample of NTG was kindly supplied by Glenmark 
Pharmaceuticals, Mumbai, India, as gift. Stock standard 200μg/mL 
NTG solutions were prepared by dissolving 20mg of pure NTG in 
0.1M NaOH and 0.1MHCl separately, and diluted to 100mL with the 
respective solvent, in calibrated flasks. The solutions were diluted to 
obtain 60 and 80 μg/mL NTG and used for assay by NaOH method 
and HCl method, respectively.
NTG - containing tablets; Natilide-60 (60mg) (Alembic Ltd., 
Vadodara, India), Glinate-60 (60mg) (Glenmark Pharma. Mumbai, 
India) were purchased from the local market.
Assay procedures
Procedure for bulk drug:
NaOH Method: Varying aliquots (0.5, 1.0, 2.0,…. 9.0 mL) of 
60μg/mL NTG standard solution were taken in a series of 10mL 
volumetric flasks and volume was made up to the mark with 0.1M 
NaOH. The absorbance of each solution was measured at 210nm vs 
0.1M NaOH.
HCl Method: Into a series of 10mL calibration flasks, aliquots 
of NTG standard solution equivalent to 4.0-72.0 μg/mL NTG were 
accurately transferred and volume was made up to the mark with 
0.1M HCl. The absorbance of each solution was measured at 270nm 
vs0.1M HCl.
In either method, calibration curve was prepared by plotting 
absorbance versus concentration. The concentration of the unknown 
was computed from the respective regression equation derived using 
Beer’s law data.
Procedure for tablets:
Twenty tablets from each brand were weighed and crushed into 
a fine powder. An amount of tablet powder equivalent to 20mg of 
Parameter NaOH Method HCl Method
λmax, nm 210 270
Beer’s law limits, µg/mL 3.0–54.0 4.0–72.0
Molar absorptivity(ε), L/mol/cm-1 4.09×103 3.04×103
Sandell sensitivity, µg/cm2 0.0776 0.0995
Limit of detection (LOD), µg/mL 0.91 0.72
Limit of quantification (LOQ), µg/mL 2.73 2.16
Regression equation, Y*
Intercept (b) 0.0095 0.0102
Slope (m) 0.0169 0.0126
Correlation coefficient (r) 0.9995 0.9997
Standard deviation of intercept (Sb) 0.0027 0.0067
Standard deviation of slope (Sm) 0.0003 0.0002
Table 1: Sensitivity and regression parameters.
*y= mx+b, where y is the absorbance, x concentration in µg/mL, b intercept and 
m slope.
Method NTG taken(µg/mL)






















































Table 2: Results of intra-day and inter-day accuracy and precision study.
aMean value of five determinations; bRelative standard deviation (%); cRelative 
error (%).








15 1.25 1.02 1.04
30 0.96 1.21 1.54
45 1.41 0.91 0.78
HCl method
20 0.63 1.57 1.09
40 1.16 0.72 1.53
60 0.72 0.82 1.19
Table 3: Results of ruggedness expressed as intermediate precision, expressed 
as %RSD.
*The wavelengths were 209, 210 and 211 nm (NaOH method) and 269, 270 and 
271 nm (HCl method).
Figure 4A: UV-spectra of 40 μg mL-1 NTG after subjecting to acid hydrolysis: a) NaOH Method and b) HCl Method.
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NTG was transferred into two 100mL separate volumetric flasks. 
The content was shaken well for 20min with about 50 mL of 0.1M 
NaOH or 0.1M HCl and the content was diluted to the mark with the 
respective solvent. It was filtered using Whatman No. 42 filter paper. 
First 10mL portion of the filtrate was discarded and appropriate 
portions were diluted to get 60 and 80 μg/mL NTG levels separately 
using the respective solvent, and a suitable aliquot was taken for 
absorbance measurement.
Procedure for placebo blank and synthetic mixture 
analyses
A placebo blank of the composition: acacia (10mg), starch 
(15mg), hydroxyl cellulose (15mg), sodium citrate (10mg), 
magnesium stearate (10mg), talc (15mg) and sodium alginate 
(15mg) was prepared by homogeneous mixing. A 20mg portion was 
extracted with either 0.1N NaOH or 0.1N HCl as described under 
“procedure for tablets”. A 2 mL aliquot was taken for assay following 
Figure 4B: UV-spectra of 40 μg mL-1 NTG after subjecting to base hydrolysis: a) NaOH method and b) HCl method.
Figure 4C: UV-spectra of 40 μg mL-1 NTG after subjecting to oxidative condition: a) NaOH method and b) HCl method.
Figure 4D: UV-spectra of 40 μg mL-1 NTG after subjecting to thermal degradation: a) NaOH method and b) HCl method.
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the recommended procedure. A synthetic mixture was prepared by 
adding 20 mg pure NTG to 20mg placebo blank and homogenized. 
Its solution was prepared as described under “procedure for tablets”. 
The extract was subjected to assay following the general procedures 
(n=5) after appropriate dilution and the percentage recovery of NTG 
was calculated in each method.
Procedure for forced degradation study
Two standard solutions equivalent to 200μg/mL NTG were 
prepared in 0.1M NaOH and 0.1M HCl separately. Two mL each 
of this solution were accurately transferred into separate 10mL 
volumetric flasks. One mL of 5M HCl, 5M NaOH or 5% H2O2 was 
added to the flasks separately and the flasks were heated for 2h in 
a water bath maintained at 80°C. Then, the solutions were cooled 
to room temperature and neutralized by adding base or acid; the 
volume in each flask was brought to the mark with the respective 










NaOH method HCl method
Natelide-60 60 99.87±1.03
101.5±1.12 101.9±1.45
t = 2.39 t  = 2.55
F= 1.18 F = 1.98
Glinate-60 60 99.96±1.89
101.2±1.63 102.1±1.89
t = 1.11 t  = 1.87
F= 1.34 F = 1.21
Table 4: Results obtained by the analysis of tablets by the proposed methods 
and statistical comparison of results with the reference method.
aMean value of five determinations.
Tablet studied












































































Table 5: Results of recovery study using standard addition method.
*Mean value of three determinations.
solvent, and absorbance measured at 210nm (NaOH method) or 
270nm (HCl method). For thermal degradation, solid drug was kept 
in Petri dish in an oven at 100°C for 24h. To study the effect of light 
solid sample was exposed to 1200K lux intensity light for 48h in an 
uv chamber. Solid samples after degradation were used to prepare 60 
and 80 μg/mL solution in 0.1M NaOH and 0.1M HCl, respectively. 
Finally, the absorbance of solutions from acid, base, oxidant, heat and 




NTG solutions in 0.1M NaOH and 0.1M HCl showed absorbance 
maxima at 210 and 270 nm, respectively, and absorbance at 
these wavelengths was found to be linearly dependent upon the 
concentration of drug. The corresponding blank solutions showed 
negligible absorbance as shown in Figure 2.
Method validation
Linearity, sensitivity, limits of detection and quantification: 
A linear correlation was found between absorbance at λmax and 
concentration of NTG (Figure 3). The slope (m), intercept (b) and 
correlation coefficient (r) for each system were evaluated by using 
the method of least squares. Optical characteristics such as Beer’s 
law limits, molar absorptivity and Sandell sensitivity values [54] of 
both the methods were calculated. The limits of detection (LOD) and 
quantitation (LOQ) were also calculated according to ICH guidelines 
[55], and all these data are presented in Table 1.
Precision and accuracy: To check the repeatability and 
reproducibility of the proposed methods, the assays described under 
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“general procedures” were repeated seven times within the day 
(intra-day precision) and five times on five successive days (inter-day 
precision). These assays were performed for three levels of analyte. 
The RSD values were ≤ 1.45% (intra-day) and ≤ 1.63% (inter-day), 
indicating very good precision of the methods. The accuracy of the 
methods was evaluated as percentage relative error, %RE, between 
the measured mean concentrations and nominal concentrations for 
NTG. The %RE values of ≤ 2.0% demonstrate high accuracy of the 
proposed methods. The results of this study are summarized in Table 
2.
Robustness and ruggedness: Robustness was determined by the 
analysis of standard solution at three concentration levels at three 
wavelengths (λmax and λmax±1nm). Analyses were also performed 
by three analysts using the same cuvette and a single analyst using 
three cuvettes in the same laboratory. Intermediate %RSD values in 
both instances were in the range 0.63–1.57% indicating acceptable 
robustness and ruggedness. These results are presented in Table 3.
Selectivity: Selectivity of the methods was assessed by placebo 
blank and synthetic mixture analyses. The absorbance of the placebo 
blank was the same as that of 0.1M NaOH or 0.1M HCl. When the 
synthetic mixture solution was subjected to analysis at 30 and 40 
μg/mL concentration levels by NaOH method & HCl method, the 
percent recoveries were 97.36 and 98.72, respectively, with %RSD 
being less than 2.2, implying that the assays were free from matrix 
interference.
Application to tablets: Commercial NTG tablets were analyzed 
by the developed methods and also by the official USP method [23]. 
Tablet powder extract was analysed by HPL using phosphate buffer 
and methanol system as mobile phase with uv detection at 210 nm. 
The results obtained were compared statistically by the Student’s 
t-test and the variance-ratio F-test. The calculated t- and F- values 
did not exceed the tabulated values of 2.77 and 6.39, respectively, at 
the 95% confidence level and for four degrees of freedom (Table 4), 
indicating close similarity between the proposed methods and the 
reference method with respect to accuracy and precision.
Accuracy by recovery study: To ascertain the accuracy and 
reliability of the proposed methods, recovery test was performed via 
standard-addition procedure. Pre-analyzed tablet powder was spiked 
with pure NTG at three different levels and the total was determined 
by the proposed methods. Each determination was repeated three 
times. The percent recovery of pure NTG added was within the 
acceptable limits, indicating the absence of interference from the 




NaOH method HCl method
Acid hydrolysis No degradation No degradation
Alkali hydrolysis 15.5 29.8
Oxidation 99.9% 99.8%
Thermal (105°C, 3 hours) No degradation No degradation
Photolytic (1.2 million lux hours) No degradation No degradation
Table 6: Results of stability indicating study by forced degradation study.
*Mean value of three determinations.
Results from forced degradation study
The susceptibility to degradation was evaluated by measuring the 
absorbance of NTG solution after subjecting the sample to forced 
degradation. The percentage recovery of NTG was calculated in each 
case and is presented in Table 4. From this study, it can be concluded 
that the drug remained inert to acid hydrolysis, thermal and 
photolytic degradation. NTG degraded slightly under base-induced 
stress condition. Oxidative degradation was very extensive and the 
analyte was undetectable at the selected wavelengths. Chromatograms 
of 40µg/mL NTG solution, post degradation, are shown in Figure 4A 
to 4E.
Conclusions
The study presents two rapid and useful uv-spectrophotometric 
methods, which are stability-indicating, for the determination of 
nateglinide in pharmaceutical samples. Majority of the reported 
methods [43-52] employ organic solvents as diluents and suffer 
from two disadvantages of narrow linear dynamic range and poor 
sensitivity. The proposed methods use inexpensive chemicals as 
diluents and characterized by wide linear dynamic ranges and often 
more sensitive than the reported uv-spectrophotometric methods 
interms of LOD. High accuracy and precision of the methods, besides 
ease of performance and speed make them suitable for routine use.
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